YAZEN.COMManage supplier listing
Yazen Health AB — Longitudinal real-world obesity/GLP-1 treatment cohort from a digital weight-management program: per-patient prescription and refill sequences for GLP-1 receptor agonists, prospectively recorded discontinuation reason codes, paired lifestyle-intervention exposure (coaching and behavioral program engagement), weight trajectory, and physician-guided treatment decisions — published as a Swedish cohort of 25,824 patients. Mid-size Nordic digital-health operator: ~290 employees, ~$36M revenue band, $32.4M raised, one published cohort already at 25,824 patients with 24-month follo…
Datasets
1Longitudinal real-world obesity/GLP-1 treatment cohort from a digital weight-management program: per-patient prescription and refill sequences for GLP-1 receptor agonists, prospectively recorded discontinuation reason codes, paired lifestyle-intervention exposure (coaching and behavioral program engagement), weight trajectory, and physician-guided treatment decisions — published as a Swedish cohort of 25,824 patients
Scale Stated cohort of 25From 5 yearsCoverage Health Care
Sample, licence terms, pricing and eval results when Yazen Health AB publishes them. Until then, discover alternatives today with a 7-day trial.
Start 7-day trial →Questions
What buyers ask about Yazen Health AB, answered from this page.
What does Yazen Health AB do?
Yazen Health AB — Longitudinal real-world obesity/GLP-1 treatment cohort from a digital weight-management program: per-patient prescription and refill sequences for GLP-1 receptor agonists, prospectively recorded discontinuation reason codes, paired lifestyle-intervention exposure (coaching and behavioral program engagement), weight trajectory, and physician-guided treatment decisions — published as a Swedish cohort of 25,824 patients. Mid-size Nordic digital-health operator: ~290 employees, ~$36M revenue band, $32.4M raised, one published cohort already at 25,824 patients with 24-month follo…
What data does Yazen Health AB offer?
Yazen Health AB offers (Alternative, Fundamental) — Stated cohort of 25,824 patients observed to 24 months; estimate several million longitudinal records across visits, prescriptions, refills, weight measurements and program-engagement events (each patient contributing dozens to hundreds of time-stamped rows over a multi-year episode).
What is Yazen Health AB's data used for?
GLP-1 persistence benchmarking against trial populations, discontinuation-cause modeling (price sensitivity vs tolerability vs efficacy perception), adherence-intervention and coaching-effectiveness causal analysis, digital-therapeutic adjunct evaluation, obesity-drug cost-effectiveness and budget-impact modeling, manufacturer market-access evidence for European payers, weight-maintenance and relapse modeling
How is Yazen Health AB's data delivered?
The data is with 5 years of history.
What does Yazen Health AB cover?
Coverage spans Other, US; Health Care Technology, Pharmaceuticals; alternative, fundamental; equities.
Yazen Health AB has not added their own details yet. Not yet on file:
- Summary & mission
- People
- Use cases & buyers
- FAQ